Med in Preggo

    Cards (64)

    • Placenta
      Lipophilic unionized small mw drugs can cross the placenta and as the placenta thins the drug exposure increases
    • Foetus is at risk

      When drugs cross the placenta
    • Drugs are <0.2% cause of all live birth abnormalities
    • Abnormalities may be detected at birth or take years to identify
    • Types of potential adverse effects
      • Neurodevelopmental/ behavioural effects
      • Foetal malformation
      • Intra-uterine growth retardation
      • Premature birth and still birth
      • Obstetric complications
      • Neonatal s/e
      • Ovarian cancer
    • Neurodevelopmental/ behavioural effects
      • sodium valproate, phenytoin, alcohol
    • Foetal malformation
      • isotretinoin (cleft palate, external ear/ eye/ thymus and parathyroid abnormalities (no eye ball), ↓ septum (brain) growth)
    • Intra-uterine growth retardation

      • cocaine
    • Premature birth and still birth
      • theophylline
    • Obstetric complications
      • Aspirin, NSAIDs that are taken closer to term
    • Neonatal s/e
      • TCS, SSRI
    • Ovarian cancer

      • diethylstilbesterol
    • Teratogens
      • ACE inhibitors
      • sodium valproate
      • hypoglycaemics
      • methotrexate
      • warfarin
    • Stage of pregnancy
      Influences choice of medicine
    • Drug dosage
      No safe dosage publications
    • Frequency of ingestion
      Increased drug accumulation which can lead to toxicity if it crosses the placenta
    • Mother's nutritional status
      Folic acid? Vitamin D 10 mcg daily?
    • Genetics
      Foetal hydantoin syndrome
    • Prescribing principles
      • Consider the possibility of pregnancy in all women of childbearing age
      • Use non-pharmacological treatments where possible
      • Avoid medicines use as much as possible in pregnancy
      • Where drugs are needed, use the one with the best-known safety profile
      • Use the lowest effective dose for the shortest possible time, where appropriate
      • Long term conditions – medication review prior to pregnancy
      • Compliance important – drug may be less harmful than condition
      • Close monitoring may be required
      • Consider route of administration
    • Folic acid
      Neural tube defect, Women at a normal risk of 400 mcg daily pre-conception up to 12-week preggo, Women at HIGH risk: 5mg daily up to the 12th week preggo or until birth if a woman with thalassaemia trait, Folic is synthetic form which is highly bioavailable and stable unlike folate (natural form) found in greens
    • Access to balanced information vital
    • Indication
      • Asthma (8%)
      • Diabetes (5%)
      • Hypertension (10%)
      • Epilepsy (1%)
      • Depression (20%)
    • Asthma
      • One SABA, LABA
      • One inhaled corticosteroid (oral are continued → benefit>risk(oral cleft))
      • Oral and IV theophylline – TDM
      • Leukotriene receptor antagonist (only if necessary)
    • Asthma complications

      hypertensive disorders, intrauterine growth retardation, preterm labour and delivery
    • Maximize lung fxn → ↓ risk of an asthma attack
    • Diabetes
      • Monitor (Fasting, 1hr post meal & bedtime daily, Ideal HbA1C < 48mmol/moL (6.5%), Fasting: 5.33mmol/litre, 1hr post meal: 7.88mmol/litre (in general keep glucose >4 mmol/litre))
      • Diet and exercise
      • Metformin (for T2D , also can be an adjunct or alternative to insulin)
      • Insulin
    • Diabetes complications
      Obstetric: miscarriage, pre-eclampsia, pre-term labour, Foetal / neonatal complications: stillbirth, macrosomia (large baby), birth injury
    • Substitution for any previously used oral anti-diabetic/ metformin is CI
    • Nausea/vomiting disrupts eating (change time/dose of insulin)
    • Lower threshold for glycosuria
    • Co-prescribed meds for diabetes
      • Folic acid 5 mg until 12 weeks of gestation
      • Aspirin 75mg started in all ladies w/ pre-existing T1/T2 diabetes or at risk of pre-eclampsia
    • Hypertension
      • Chronic Hypertension
      • Preggo induced hypertension
      • Pre-eclampsia
    • Hypertension target
      <135/85 mmHg / if chronic hypertension <140/90 mmHg if too low → fetal growth affected
    • Hypertension 1st line
      • Labetalol (Lic1) –100mg BD
    • Hypertension 2nd line

      • Nifedipine
    • Avoid ACE: PRIL, ARB: SARTAN, Diuretics: Furosemide (↓ plasma), Chlorothiazide – even in breastfeeding
    • Hypertension complications
      Risk of gestational diabetes, Effect of proteinuria (Liver damage, Placenta rupture, Kidney damage)
    • Other hypertension meds
      • Methyldopa(lic)– 250mg BD/TDS
      • Aspirin 75 mg
    • Avoid methyldopa in pregnancy with depression
    • Two days post birth- switch back to normal ACE/ARBs , avoid risk of depression
    See similar decks